Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Heart Failure × Carvedilol × Clear all

Phase

Status

Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3 Cardiotoxicity 2 Ventricular Dysfunction 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Multiple Myeloma 1 Lymphoma 1 Leukemia, Myeloid, Acute 1 Hematologic Neoplasms 1 Heart Failure 1 Breast Neoplasms, Male 1

Interventions

Electrocardiography 3 Echocardiography 3 Surveys and Questionnaires 2 ziprasidone 1 candesartan 1 Zolpidem 1 Warfarin 1 Vecuronium Bromide 1 Vascular Stiffness 1 Vancomycin 1 Tranexamic Acid 1 Tobramycin 1 Spironolactone 1 Sodium Chloride 1 Simendan 1 Sevelamer 1 Rocuronium 1 Pulse Wave Analysis 1 Piperacillin, Tazobactam Drug Combination 1 Pentobarbital 1 Palliative Care 1 Oxycodone 1 Nutrition Assessment 1 Nifedipine 1 Nafcillin 1 Molindone 1 Metoprolol 1 Methylprednisolone 1 Massage 1 Lysine Acetyltransferase 5 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01724450 2018-02-05

Ceccy

University of Sao Paulo

Phase 3 Completed

Breast Neoplasms, Heart Failure, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡